PUNE, India, May 2, 2024 /PRNewswire/ -- The report titled "Neurovascular Intervention Devices Market by Product (Balloon ...

The global flow diverters market is on track for remarkable growth, with revenues anticipated to reach a staggering US$ 1.3 ...

In a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed how his company is using artificial intelligence and machine learning to create new drugs. Recursion ...

According to a recent report by Market.us, the Global Neurovascular Catheters Market size is expected to be worth around USD 7.5 Billion by 2032 from USD 3.7 Billion in 2023, growing at a CAGR of 8.2% ...

In the latest quarter, 7 analysts provided ratings for Penumbra (NYSE:PEN), showcasing a mix of bullish and bearish ...

The catheters approved by the FDA include the Plato 17, a DMSO-compatible microcatheter, and the Socrates 38, an aspiration catheter specifically designed for treating ischemic strokes.

Scientia Vascular announced FDA clearance of the Plato 17 microcatheter and Socrates 38 aspiration catheter. According to ...

WEST VALLEY CITY, Utah, May 6, 2024 /PRNewswire/ -- Scientia Vascular, a leader in neurovascular innovation, is thrilled to ...

The eShunt System includes an endovascularly implantable cerebral spinal fluid shunt and associated delivery components.

In patients with acute stroke and a large infarct of unrestricted size, thrombectomy and medical care led to better ...

Penumbra, Inc. announced the CE Mark approval and the launch in Europe of three of its neurovascular reperfusion ...

New program at Jerusalem's Shaare Zedek Medical Center gives a strong foundation to startups poised to make significant ...